Skip to Main Content

Paper Details

Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy.
JAMA Oncol
34
2022
Author NameAffiliation
Chiaojung Jillian TsaiMemorial Sloan Kettering Cancer Center
Sean M McBrideMemorial Sloan Kettering Cancer Center
Nadeem RiazMemorial Sloan Kettering Cancer Center
Richard J WongMemorial Sloan Kettering Cancer Center
David G PfisterMemorial Sloan Kettering Cancer Center
Eric J ShermanMemorial Sloan Kettering Cancer Center
Nancy Y LeeMemorial Sloan Kettering Cancer Center
  • 1 - 7

Datasets

Release 1.2